Document Detail


Pregnancy: maternal and fetal heart disease.
MedLine Citation:
PMID:  17643825     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac disorders complicate less than 1% of all pregnancies. Physiologic changes in pregnancy may mimic heart disease. In order to differentiate these adaptations from pathologic conditions, an in-depth knowledge of cardiovascular physiology is mandatory. A comprehensive history, physical examination, electrocardiogram, chest radiograph, and echocardiogram are sufficient in most cases to confirm the diagnosis. Care of women with cardiac disease begins with preconception counseling. Severe lesions should be taken care of prior to contemplating pregnancy. Management principles for pregnant women are similar to those for the non-pregnant state. A team approach comprised of a maternal fetal medicine specialist, cardiologist, neonatologist, and anesthesiologist is essential to assure optimal outcome for both the mother and the fetus. Although fetal heart disease complicates only a small percentage of pregnancies, congenital heart disease causes more neonatal morbidity and mortality than any other congenital malformation. Unfortunately, screening approaches for fetal heart disease continue to miss a large percentage of cases. This weakness in fetal screening has important clinical implications, because the prenatal detection and diagnosis of congenital heart disease may improve the outcome for many of these fetal patients. In fact, simply the detection of major heart disease prenatally can improve neonatal outcome by avoiding discharge to home of neonates with ductal-dependent congenital heart disease. Fortunately, recent advances in screening techniques, an increased ability to change the prenatal natural history of many forms of fetal heart disease, and an increasing recognition of the importance of a multidisciplinary, team approach to the management of pregnancies complicated with fetal heart disease, together promise to improve the outcome of the fetus with congenital heart disease.
Authors:
Afshan B Hameed; Mark S Sklansky
Related Documents :
18297615 - Maternal hydration status affects renal pelvic-calyceal diameter in pregnancy.
8055765 - Famotidine in the management of gastro-oesophageal reflux.
15037925 - A review of systemic retinoid therapy for acne and related conditions.
12681865 - Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory p...
22537115 - Usefulness of tissue transglutaminase type 2 antibodies in early pregnancy.
15946165 - Neuroendocrine regulation of prolactin secretion during late pregnancy: easing the tran...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current problems in cardiology     Volume:  32     ISSN:  0146-2806     ISO Abbreviation:  Curr Probl Cardiol     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-07-23     Completed Date:  2007-09-20     Revised Date:  2007-10-30    
Medline Journal Info:
Nlm Unique ID:  7701802     Medline TA:  Curr Probl Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  419-94     Citation Subset:  IM    
Affiliation:
Maternal Fetal Medicine and Cardiology, University of California, Irvine, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiovascular Agents / therapeutic use*
Cardiovascular Diseases* / congenital,  drug therapy,  physiopathology
Delivery, Obstetric
Female
Fetal Diseases / diagnosis*
Humans
Pregnancy
Pregnancy Complications, Cardiovascular* / diagnosis,  drug therapy,  prevention & control
Prenatal Diagnosis
Risk Factors
Chemical
Reg. No./Substance:
0/Cardiovascular Agents
Comments/Corrections
Erratum In:
Curr Probl Cardiol. 2007 Oct;32(10):600

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Attempts to detect synergy between vaccination and anthelmintic against a drug resistant isolate of ...
Next Document:  Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line.